Public Health

Is US Policy Ignoring Long COVID's Lasting Harm?
Clinical & Pharma Is US Policy Ignoring Long COVID's Lasting Harm?

With the official end of the COVID-19 pandemic declared over a year ago, many are moving on. Yet, a steady stream of research reveals a more complicated and concerning picture of the virus's long-term impact on our bodies and brains. To unpack these findings and what they mean for public health,

How Will New Research Stop Blindness and Brain Decline?
Clinical & Pharma How Will New Research Stop Blindness and Brain Decline?

Two of the most feared health challenges facing humanity are the slow, irreversible loss of sight and the devastating decline of the mind, yet a new wave of research is targeting the root causes of these conditions with unprecedented ambition. Supported by prestigious innovation grants designed to

What Is the Price of a Broken Hip in India?
Tech & Innovation What Is the Price of a Broken Hip in India?

Today we're joined by James Maitland, a leading expert on the complex intersection of healthcare law, corporate accountability, and the pharmaceutical industry. He has spent decades analyzing how multinational corporations navigate legal systems and the profound impact their actions have on

Stanford Study Reveals Secret to Scar-Free Facial Healing
Clinical & Pharma Stanford Study Reveals Secret to Scar-Free Facial Healing

The common observation that a cut on the cheek often vanishes while a similar injury on an arm leaves a permanent mark has long been a medical curiosity, but a groundbreaking study from Stanford Medicine has now unraveled the precise biological reasons for this phenomenon. By investigating the

Is This the Future of Connecticut Pediatric Care?
Clinical & Pharma Is This the Future of Connecticut Pediatric Care?

A significant shift in the landscape of pediatric medicine is taking shape in Connecticut, marked by a landmark joint announcement from two of the state's most influential health and academic institutions. Connecticut Children’s and the University of Connecticut (UConn) School of Medicine have

Medicaid Pays for Gene Therapy Only if It Works
Clinical & Pharma Medicaid Pays for Gene Therapy Only if It Works

A life once dictated by the unceasing rhythm of pain and the sterile confines of a hospital room has been fundamentally rewritten for Serenity Cole, an 18-year-old from St. Louis whose story embodies both the immense promise and the staggering financial challenge of modern medicine. For years,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later